These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 25636932
1. Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: a retrospective multicenter case-control study. Clemente W, Vidal E, Girão E, Ramos AS, Govedic F, Merino E, Muñoz P, Sabé N, Cervera C, Cota GF, Cordero E, Mena A, Montejo M, López-Medrano F, Aguado JM, Fernandes P, Valerio M, Carratalá J, Moreno A, Oliveira J, Mourão PH, Torre-Cisneros J. Clin Microbiol Infect; 2015 Jan; 21(1):89-95. PubMed ID: 25636932 [Abstract] [Full Text] [Related]
2. Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: A case series from Spain. Pérez-Jacoiste Asín MA, Carrasco-Antón N, Fernández-Ruiz M, San Juan R, Alonso-Moralejo R, González E, Andrés A, López-Medrano F, Aguado JM. Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27768239 [Abstract] [Full Text] [Related]
4. Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Basset D, Faraut F, Marty P, Dereure J, Rosenthal E, Mary C, Pratlong F, Lachaud L, Bastien P, Dedet JP. Microbes Infect; 2005 Oct; 7(13):1370-5. PubMed ID: 16046170 [Abstract] [Full Text] [Related]
5. Visceral leishmaniasis in the early post-transplant period after kidney transplantation: clinical features and therapeutic management. Veroux M, Corona D, Giuffrida G, Cacopardo B, Sinagra N, Tallarita T, Giaquinta A, Zerbo D, Veroux PF. Transpl Infect Dis; 2010 Oct; 12(5):387-91. PubMed ID: 20534033 [Abstract] [Full Text] [Related]
7. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Fernàndez-Sabé N, Cervera C, Fariñas MC, Bodro M, Muñoz P, Gurguí M, Torre-Cisneros J, Martín-Dávila P, Noblejas A, Len O, García-Reyne A, Del Pozo JL, Carratalà J. Clin Infect Dis; 2012 Feb 01; 54(3):355-61. PubMed ID: 22075795 [Abstract] [Full Text] [Related]
9. Current approaches to visceral leishmaniasis treatment in solid organ transplant recipients. Clemente WT, Mourão PHO, Aguado JM. Expert Rev Anti Infect Ther; 2018 May 01; 16(5):391-397. PubMed ID: 29737887 [Abstract] [Full Text] [Related]
10. Leishmaniasis among organ transplant recipients. Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M. Lancet Infect Dis; 2008 Mar 01; 8(3):191-9. PubMed ID: 18291340 [Abstract] [Full Text] [Related]
11. Visceral leishmaniasis in renal transplant recipients: clinical aspects, diagnostic problems, and response to treatment. Oliveira CM, Oliveira ML, Andrade SC, Girão ES, Ponte CN, Mota MU, Fernandes PF, Campos HH, Esmeraldo RM, Evangelista JB. Transplant Proc; 2008 Apr 01; 40(3):755-60. PubMed ID: 18455008 [Abstract] [Full Text] [Related]
12. Environmental Factors as Key Determinants for Visceral Leishmaniasis in Solid Organ Transplant Recipients, Madrid, Spain. Carrasco-Antón N, López-Medrano F, Fernández-Ruiz M, Carrillo E, Moreno J, García-Reyne A, Pérez-Ayala A, Rodríguez-Ferrero ML, Lumbreras C, San-Juan R, Alvar J, Aguado JM. Emerg Infect Dis; 2017 Jul 01; 23(7):1155-1159. PubMed ID: 28628447 [Abstract] [Full Text] [Related]
13. [Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection]. Reus S, Sánchez R, Portilla J, Boix V, Priego M, Merino E, Román F. Enferm Infecc Microbiol Clin; 1999 Dec 01; 17(10):515-20. PubMed ID: 10650648 [Abstract] [Full Text] [Related]
14. Visceral leishmaniasis in an infant following a holiday trip to Spain. Trück J, Rampton C, Kelly SJ, Kelly D. BMJ Case Rep; 2015 Apr 28; 2015():. PubMed ID: 25920739 [Abstract] [Full Text] [Related]
15. Prognostic factors for death from visceral leishmaniasis in patients treated with liposomal amphotericin B in an endemic state in Brazil. Dias Tourinho B, Figueiredo Amâncio F, Lencine Ferraz M, Carneiro M. Trans R Soc Trop Med Hyg; 2017 Apr 01; 111(4):163-171. PubMed ID: 28673017 [Abstract] [Full Text] [Related]
16. HIV/AIDS-related visceral leishmaniasis: a clinical and epidemiological description of visceral leishmaniasis in northern Brazil. Albuquerque LC, Mendonça IR, Cardoso PN, Baldaçara LR, Borges MR, Borges Jda C, Pranchevicius MC. Rev Soc Bras Med Trop; 2014 Apr 01; 47(1):38-46. PubMed ID: 24603735 [Abstract] [Full Text] [Related]
17. The risk factors for and effects of visceral leishmaniasis in graft and renal transplant recipients. Alves da Silva A, Pacheco-Silva A, de Castro Cintra Sesso R, Esmeraldo RM, Costa de Oliveira CM, Fernandes PF, Oliveira RA, Silva LS, Carvalho VP, Nery Costa CH. Transplantation; 2013 Mar 15; 95(5):721-7. PubMed ID: 23388734 [Abstract] [Full Text] [Related]
18. [The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection]. Delgado Fernández M, García Ordoñez MA, Martos Pérez F, Reguera Iglesias JM, Jiménez Oñate F, Colmenero Castillo JD. An Med Interna; 1997 Oct 15; 14(10):506-10. PubMed ID: 9424140 [Abstract] [Full Text] [Related]
19. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil. Daher EF, Fonseca PP, Gerhard ES, Leitão TM, Silva Júnior GB. J Parasitol; 2009 Jun 15; 95(3):652-5. PubMed ID: 19642802 [Abstract] [Full Text] [Related]
20. Visceral leishmaniasis in adults with nephropathy. El Jeri HK, Harzallah A, Barbouch S, Bacha MM, Kheder R, Turki S, Trabelsi S, Abderrahim E, Hamida FB, Abdallah TB. Saudi J Kidney Dis Transpl; 2017 Jun 15; 28(1):95-101. PubMed ID: 28098109 [Abstract] [Full Text] [Related] Page: [Next] [New Search]